(0.03%) 5 470.68 points
(0.00%) 39 111 points
(0.33%) 17 777 points
(-0.48%) $80.44
(-4.50%) $2.63
(-0.85%) $2 311.00
(0.01%) $28.87
(2.29%) $1 009.00
(0.27%) $0.936
(0.65%) $10.67
(0.45%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics...
Stats | |
---|---|
Today's Volume | 20 366 |
Average Volume | 0 |
Market Cap | 419.71M |
EPS | $-0.190 ( Q1 | 2024-05-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-02 | Foehr Matthew W | Buy | 33 173 | Common Stock |
2024-01-02 | Foehr Matthew W | Sell | 13 221 | Common Stock |
2024-01-02 | Foehr Matthew W | Sell | 33 173 | Restricted Stock Units |
2024-01-02 | Berkman Charles S | Buy | 17 556 | Common Stock |
2024-01-02 | Berkman Charles S | Sell | 7 195 | Common Stock |
INSIDER POWER |
---|
76.05 |
Last 81 transactions |
Buy: 3 986 118 | Sell: 400 743 |
OmniAb, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
OmniAb, Inc. Financials
Annual | 2023 |
Revenue: | $34.16M |
Gross Profit: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2023 |
Revenue: | $34.16M |
Gross Profit: | $14.67M (42.93 %) |
EPS: | $-0.510 |
FY | 2022 |
Revenue: | $59.08M |
Gross Profit: | $42.83M (72.49 %) |
EPS: | $-0.260 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
OmniAb, Inc.
OmniAb, Inc., a biotechnology company, provides therapeutic antibody discovery technologies in the United States. The company\'s discovery platform provides industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company\'s OmniFlic (transgenic rat) and OmniClic (transgenic chicken) address industry needs for bispecific antibody applications though a common light chain approach, and OmniTaur that features unique structural attributes of cow antibodies for complex targets. The company was founded in 2012 and is headquartered in Emeryville, California.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators